酚妥拉明和垂体后叶素联合法治疗肺结核咯血临床疗效和安全性观察

摘要

目的：探讨联合酚妥拉明﹑垂体后叶素治疗肺结核咯血疗效﹑安全性。方法将122例肺结核咯血患者分为对照组(垂体后叶素治疗)﹑观察组(垂体后叶素联合酚妥拉明治疗)﹐观察疗效﹑安全性。结果两组总有效率(95.4﹪VS 78.9﹪)﹐不良反应发生率(6.2﹪VS 26.3﹪)﹐<0.05。结论酚妥拉明﹑垂体后叶素联合法治疗肺结核咯血疗效显著﹐安全性高。%Objective Discussion joint phentolamine,vasopressin treatment of tuberculosis hemoptysis efficacy,safety. Methods The 122 cases of lung tuberculosis patients were divided into a control group (vasopressin treatment),the observation group (vasopressin joint phentolamine treatment), efficacy and safety. Results The total effective rate (95.4%VS78.9%),incidence of adverse reactions (6.2%VS26.3%), <0.05.Conclusion Phentolamine,vasopressin combined method of treatment of tuberculosis hemoptysis significant effect,safe.